Cover Image

ANTITHROMBOTIC THERAPY AT PERCUTANEOUS CORONARY INTERVENTIONS

Possibilities of modern antiplatelet and antithrombotic therapy at percutaneous coronary interventions in patients with coronary artery disease are surveyed. Data of multicenter randomized clinical trials and meta-analyses are discussed. Possibilities of various drugs at percutaneous coronary interv...

Full description

Saved in:

Bibliographic Details
Main Author:	V. A. Sulimov (Author)
Format:	Book
Published:	Столичная издательская компания, 2016-01-01T00:00:00Z.
Subjects:	article
Online Access:	Connect to this object online.
Tags:	Add Tag No Tags, Be the first to tag this record!

Similar Items

Antithrombotic Management for Patients with Atrial Fibrillation Undergoing Percutaneous Coronary Intervention
by: A. V. Panov
Published: (2021)

Antithrombotic strategies in patients undergoing percutaneous coronary intervention for acute coronary syndrome
by: Son V Pham, et al.
Published: (2010)

Critical Appraisal of Guidelines for Antithrombotic Therapy in Atrial Fibrillation Post-Percutaneous Coronary Intervention
by: Yongqiang Fan, et al.
Published: (2022)

Pharmacoeconomic analysis of antithrombotic therapy in patients with acute coronary syndrome and patients with atrial fibrillation who underwent percutaneous coronary intervention
by: V. А. Ryagina, et al.
Published: (2023)

Antithrombotic therapy in patients with atrial fibrillation and percutaneous coronary intervention: what has changed in the guidelines in 2020?
by: E. P. Panchenko
Published: (2020)

Advances of safety of antithrombotic therapy in patients with chronic kidney disease plus atrial fibrillation after percutaneous coronary intervention
by: Jia-xuan Ning, et al.
Published: (2024)

STRATEGY TO MINIMIZE THE BLEEDING RISKS IN PATIENTS WITH ATRIAL FIBRILLATION WHO RECEIVE COMBINED ANTITHROMBOTIC THERAPY AFTER PERCUTANEOUS CORONARY INTERVENTION
by: D. A. Zateishchikov
Published: (2018)

RESISTANCE TO ANTIPLATELET DRUGS (ASPIRIN, CLOPIDOGREL) IN PATIENTS UNDERGOING ELECTIVE PERCUTANEOUS CORONARY INTERVENTION
by: V. A. Sulimov, et al.
Published: (2015)

RESISTANCE TO ANTIPLATELET DRUGS (ASPIRIN, CLOPIDOGREL) IN PATIENTS UNDERGOING ELECTIVE PERCUTANEOUS CORONARY INTERVENTION
by: V. A. Sulimov, et al.
Published: (2015)

ANTITHROMBOTIC THERAPY IN ATRIAL FIBRILLATION: NEW DATA AND NEW HORIZONS
by: M. Yu. Gilyarov, et al.
Published: (2016)

ANTITHROMBOTIC THERAPY AT AN ATRIAL FIBRILLATION: OLD PROBLEMS AND NEW SOLUTIONS
by: M. Yu. Gilyarov, et al.
Published: (2016)

ANTITHROMBOTIC THERAPY IN ATRIAL FIBRILLATION: NEW DATA AND NEW HORIZONS
by: M. Yu. Gilyarov, et al.
Published: (2016)

Bleeding risk factors and real-world antithrombotic therapies in elderly patients with atrial fibrillation undergoing percutaneous coronary intervention: a retrospective study
by: Kanako Fujita, et al.
Published: (2023)

Antithrombotic Regimens in Patients With Percutaneous Coronary Intervention Whom an Anticoagulant Is Indicated: A Systematic Review and Network Meta-Analysis
by: Wipharak Bunmark, et al.
Published: (2018)

The Use of Dual Antiplatelet Therapy in Acute Coronary Syndrome and Percutaneous Coronary Intervention
by: A. S. Tereshchenko, et al.
Published: (2019)

Comorbidities and Percutaneous Coronary Intervention in Elderly Patients with Acute Coronary Syndrome
by: M. Yu. Gilyarov, et al.
Published: (2021)

ANTITHROMBOTIC THERAPY IN CANCER PATIENTS
by: A. V. Vorobev, et al.
Published: (2016)

Modern Antiplatelet Therapy for Percutaneous Coronary Intervention. How to Make the Right Choice?
by: T. M. Uskach, et al.
Published: (2020)

HOMOCYSTEINE-LOWERING THERAPY AND LONG-TERM PROGNOSIS AFTER ELECTIVE PERCUTANEOUS CORONARY INTERVENTION
by: O. O. Shakhmatova, et al.
Published: (2016)

SOME ASPECTS OF IMPROVING ADHERENCE TO DUAL ANTITHROMBOTIC THERAPY AFTER ACUTE CORONARY SYNDROME
by: A. D. Erlikh
Published: (2017)

NEW PROSPECTS OF ANTITHROMBOTIC THERAPY IN PATIENTS WITH ATRIAL FIBRILLATIO AND CORONARY ARTERY STENTS: DABIGATRAN POTENTIAL
by: M. Yu. GILYAROV, et al.
Published: (2017)

STATINS AND PERCUTANEOUS CORONARY INTERVENTION. FOCUS ON THE ATORVASTATIN
by: N. G. Gogolashvili
Published: (2015)

STATINS AND PERCUTANEOUS CORONARY INTERVENTION. FOCUS ON THE ATORVASTATIN
by: N. G. Gogolashvili
Published: (2015)

Editorial: Primary percutaneous coronary intervention in octogenarians
by: Ertan Ökmen
Published: (2013)

Antithrombotic therapy in COVID-19 patients
by: E. V. Slukhanchuk, et al.
Published: (2023)

Actual Issues of Ischemic and Hemorrhagic Events Risk Management During Antithrombotic Therapy in Patients with Acute Coronary Syndrome
by: R. M. Velieva, et al.
Published: (2020)

Efficacy and Safety of Prolonged Dual Antiplatelet Therapy after Percutaneous Coronary Intervention in Acute Coronary Syndrome Patients
by: Jialun Han, et al.
Published: (2023)

From Coronaries to Cirrhosis: The Role of Percutaneous Coronary Intervention and Dual Antiplatelet Therapy in End-Stage Liver Disease
by: Taylor C. Remillard MD, et al.
Published: (2021)

THROMBOPHILIA, THROMBOSIS AND ANTITHROMBOTIC THERAPY IN CANCER PATIENTS
by: A. V. Vorobev, et al.
Published: (2016)

Antithrombotic therapy for long-term secondary prevention of acute coronary syndrome in high-risk patients
by: Husted S
Published: (2015)

Subdural Hemorrhage and Antithrombotic Therapy
by: J Gordon Millichap, et al.
Published: (2014)

PRASUGREL FOR THE TREATMENT OF ACUTE CORONARY SYNDROMES AND PERCUTANEOUS CORONARY INTERVENTION: STATUS UPDATE ON THE PROBLEM
by: O. O. Shakhmatova, et al.
Published: (2018)

Acute Coronary Syndrome Treated with Percutaneous Coronary Intervention in Hutchinson-Gilford Progeria
by: Luciano De Simone, et al.
Published: (2023)

The quality of life of patients with coronary artery disease after percutaneous coronary interventions
by: Karolina Hajduga, et al.
Published: (2023)

Left main coronary disease percutaneous coronary intervention: The quest to reconcile the inconsistencies
by: Juan F. Iglesias, et al.
Published: (2021)

CASE OF LEFT ATRIUM INTRAMURAL HEMATOMA AFTER PERCUTANEOUS CORONARY INTERVENTION
by: T. S. Sukhinina, et al.
Published: (2020)

Geographical and socioeconomic disparities in the use of percutaneous coronary intervention in the Philippines
by: Maria Llaine J. Callanta, et al.
Published: (2022)

Topical issues of dabigatran use in combination antithrombotic therapy in patients with acute coronary syndrome and nonvalvular atrial fibrillation
by: N. A. Novikova, et al.
Published: (2020)

Comparative Analysis of Antithrombotic Therapy in In-Patients with Atrial Fibrillation
by: V. I. Petrov, et al.
Published: (2019)

Experience with the use of combination antithrombotic therapy in a patient with acute coronary syndrome and underlying severe coronavirus infection
by: D. A. Kurenkov, et al.
Published: (2022)